Expired Study
This study is not currently recruiting Study Participants on ClinicalConnection.com. If you would like to find active studies please search for clinical trials.

Paducah, Kentucky 42003


Purpose:

To compare the efficacy of two dosages (600mg/day and 1200mg/day) of bicifadine SR with placebo for 14 weeks in reduction of chronic neuropathic patin (measured by a daily rating of pain intensity) associated with diabetic periperal neuropathy in adult outpatients. To compare the tolerability of two dosages of bicifadine SR with placebo in adult outpaitens treated for chronic neuropathic pain for 14 weeks associated with diabetic peripheral neuropathy.


Criteria:

Inclusion Criteria: - Male or female, 18 years or older - Diagnosis of type-1 or type 2 non-insulin dependent diabetes mellitus - Chronic bilateral pain due to diabetic neuropathy - Pain for at least six months - Primary pain is located in the feet - Others-contact site for information Exclusion Criteria: - Symptoms of other painful conditions - Presence of amputations other than toes - Clinically significant psychiatric or other neurological disorder - Use of certain medications - Clinically important other diseases - Pregnancy - History of alcohol or narcotic abuse within two years - Others-contact site for information


NCT ID:

NCT00553592


Primary Contact:

Study Director
Mark Roffman, PhD
XTL Bio

Ivy Raso
Phone: 845-267-0707 ext. 222
Email: iraso@xtlbio.com


Backup Contact:

Email: kbarnes@incresearch.com
Kevin Barnes, MT
Phone: 512-306-4254


Location Contact:

Paducah, Kentucky 42003
United States

Jesse Wallace, MD
Phone: 270-441-4606
Email: diargent@fourriversresearch.com

Site Status: Recruiting


Data Source: ClinicalTrials.gov

Date Processed: November 24, 2017

Modifications to this listing: Only selected fields are shown, please use the link below to view all information about this clinical trial.


Click to view Full Listing

This study is not currently recruiting Study Participants on ClinicalConnection.com. The form below is not enabled.